Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HER-2 Positive Malignant Carcinoma of Breast”

708 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 708 results

Early research (Phase 1)Study completedNCT01632332
What this trial is testing

Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer

Who this might be right for
HER2-positive Breast CancerMale Breast CancerStage II Breast Cancer+3 more
Mayo Clinic 22
Large-scale testing (Phase 3)Study completedNCT03556358
What this trial is testing

Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer

Who this might be right for
Breast CancerBreast NeoplasmsHER2-positive Breast Cancer+2 more
Tanvex BioPharma USA, Inc. 809
Testing effectiveness (Phase 2)Study completedNCT02362958
What this trial is testing

A Multi-Center Study of Lapatinib in Patients With Trastuzumab-refractory Metastatic Breast Cancer

Who this might be right for
HER2 Positive Breast Cancer
Sun Yat-sen University 159
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06595563
What this trial is testing

HER2 Molecular Imaging With 89Zr-trastuzumab PET/CT as a Predictive Biomarker for Antibody-drug Conjugate Sequencing in Patients With Advanced HER2-positive Breast Cancer

Who this might be right for
HER2-positive Metastatic Breast CancerHER2-positive Advanced Breast Cancer
Jules Bordet Institute 87
Testing effectiveness (Phase 2)Looking for participantsNCT07053085
What this trial is testing

Surgery and Radiotherapy in People With Breast Cancer

Who this might be right for
Metastatic Breast CancerHER2-positive Breast Cancer
Memorial Sloan Kettering Cancer Center 162
Post-approval studies (Phase 4)Not Yet RecruitingNCT06868017
What this trial is testing

Randomized Controlled Clinical Study of Efficacy and Safety of Initumab Combined with Pyrrotinib and Chemotherapeutic Agents in Neoadjuvant Therapy for HER2-positive Breast Cancer with Different Treatment Cycles

Who this might be right for
HER2 Positive Breast Cancer
The First Hospital of Jilin University 208
Testing effectiveness (Phase 2)Ended earlyNCT00079326
What this trial is testing

Trastuzumab and Ixabepilone in Treating Women With HER2-Positive Metastatic Breast Cancer

Who this might be right for
HER2-positive Breast CancerRecurrent Breast CancerStage IV Breast Cancer
National Cancer Institute (NCI) 39
Early research (Phase 1)Study completedNCT01423123
What this trial is testing

Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 21
Not applicableLooking for participantsNCT06446882
What this trial is testing

Diagnostic HER2DX-guided Treatment for Patients wIth Early-stage HER2-positive Breast Cancer

Who this might be right for
HER2-positive Breast CancerEarly-stage Breast Cancer
Fundacio Clinic Barcelona 304
Testing effectiveness (Phase 2)Study completedNCT00411788
What this trial is testing

A Phase II Study of Rapamycin and Trastuzumab for Patients With HER-2 Receptor Positive Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Yale University 11
Testing effectiveness (Phase 2)Study completedNCT01306942
What this trial is testing

Dasatinib In Combination With Trastuzumab And Paclitaxel In First Line Treatment Of Her2-Positive MBC Patients

Who this might be right for
Metastatic Breast Cancer
Spanish Breast Cancer Research Group 37
Early research (Phase 1)Study completedNCT04509596
What this trial is testing

DZD1516 in Combination With Trastuzumab and Capecitabine, or in Combination With T-DM1, in Patients With Metastatic HER2 Positive Breast Cancer

Who this might be right for
Breast Cancer Metastatic
Dizal Pharmaceuticals 23
Testing effectiveness (Phase 2)Study completedNCT01242449
What this trial is testing

Oral Vinorelbine in Combination With Trastuzumab for Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Vejle Hospital 10
Testing effectiveness (Phase 2)UnknownNCT03913234
What this trial is testing

Phase IB & II Study of Ribociclib With Trastuzumab Plus Letrozole in Postmenopausal HR+, HER2+ Advanced Breast Cancer Patients

Who this might be right for
HER2-positive Breast CancerPostmenopausalMetastatic Breast Cancer
Yonsei University 95
Testing effectiveness (Phase 2)Study completedNCT01669239
What this trial is testing

Study of Neoadjuvant Myocet®, Paclitaxel, Pertuzumab, and Trastuzumab in HER2-positive Breast Cancer

Who this might be right for
Breast Cancer
SOLTI Breast Cancer Research Group 83
Testing effectiveness (Phase 2)Looking for participantsNCT07233499
What this trial is testing

Evaluation of the Cardioprotective Effect of Nebivolol on Trastuzumab-Induced Cardiotoxicity in Breast Cancer Patients

Who this might be right for
HER2-positive Breast Cancer
Ain Shams University 56
Not applicableActive Not RecruitingNCT02226276
What this trial is testing

Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer

Who this might be right for
Bone MetastasesHER2-positive Breast CancerLiver Metastases+4 more
City of Hope Medical Center 10
Testing effectiveness (Phase 2)Looking for participantsNCT04585750
What this trial is testing

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Who this might be right for
Advanced Solid TumorAdvanced Malignant NeoplasmMetastatic Cancer+27 more
PMV Pharmaceuticals, Inc 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07217990
What this trial is testing

Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer

Who this might be right for
Breast CancerHER2-positive Breast CancerTriple Negative Breast Cancer
Ohio State University Comprehensive Cancer Center 84
Not applicableActive Not RecruitingNCT03165487
What this trial is testing

Comparison of the Breast Tumor Microenvironment

Who this might be right for
Triple Negative Breast CancerHormone Receptor Positive Malignant Neoplasm of Breast
Columbia University 14
Load More Results